BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36180891)

  • 21. Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase.
    Peng H; Cassel J; McCracken DS; Prokop JW; Sementino E; Cheung M; Collop PR; Polo A; Joshi S; Mandell JP; Ayyanathan K; Hinds D; Malkowicz SB; Harbour JW; Bowcock AM; Salvino J; Kennedy EJ; Testa JR; Rauscher FJ
    Mol Cancer Res; 2021 Jul; 19(7):1099-1112. PubMed ID: 33731362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia.
    Wang L; Birch NW; Zhao Z; Nestler CM; Kazmer A; Shilati A; Blake A; Ozark PA; Rendleman EJ; Zha D; Ryan CA; Morgan MAJ; Shilatifard A
    Nat Cancer; 2021 May; 2(5):515-526. PubMed ID: 35122023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids.
    Artegiani B; van Voorthuijsen L; Lindeboom RGH; Seinstra D; Heo I; Tapia P; López-Iglesias C; Postrach D; Dayton T; Oka R; Hu H; van Boxtel R; van Es JH; Offerhaus J; Peters PJ; van Rheenen J; Vermeulen M; Clevers H
    Cell Stem Cell; 2019 Jun; 24(6):927-943.e6. PubMed ID: 31130514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PR-DUB maintains the expression of critical genes through FOXK1/2- and ASXL1/2/3-dependent recruitment to chromatin and H2AK119ub1 deubiquitination.
    Kolovos P; Nishimura K; Sankar A; Sidoli S; Cloos PA; Helin K; Christensen J
    Genome Res; 2020 Aug; 30(8):1119-1130. PubMed ID: 32747411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.
    Okino Y; Machida Y; Frankland-Searby S; Machida YJ
    J Biol Chem; 2015 Jan; 290(3):1580-91. PubMed ID: 25451922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAP1 links metabolic regulation of ferroptosis to tumour suppression.
    Zhang Y; Shi J; Liu X; Feng L; Gong Z; Koppula P; Sirohi K; Li X; Wei Y; Lee H; Zhuang L; Chen G; Xiao ZD; Hung MC; Chen J; Huang P; Li W; Gan B
    Nat Cell Biol; 2018 Oct; 20(10):1181-1192. PubMed ID: 30202049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.
    Küry S; Ebstein F; Mollé A; Besnard T; Lee MK; Vignard V; Hery T; Nizon M; Mancini GMS; Giltay JC; Cogné B; McWalter K; Deb W; Mor-Shaked H; Li H; Schnur RE; Wentzensen IM; Denommé-Pichon AS; Fourgeux C; Verheijen FW; Faurie E; Schot R; Stevens CA; Smits DJ; Barr E; Sheffer R; Bernstein JA; Stimach CL; Kovitch E; Shashi V; Schoch K; Smith W; van Jaarsveld RH; Hurst ACE; Smith K; Baugh EH; Bohm SG; Vyhnálková E; Ryba L; Delnatte C; Neira J; Bonneau D; Toutain A; Rosenfeld JA; ; Audebert-Bellanger S; Gilbert-Dussardier B; Odent S; Laumonnier F; Berger SI; Smith ACM; Bourdeaut F; Stern MH; Redon R; Krüger E; Margueron R; Bézieau S; Poschmann J; Isidor B
    Am J Hum Genet; 2022 Feb; 109(2):361-372. PubMed ID: 35051358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BAP1 constrains pervasive H2AK119ub1 to control the transcriptional potential of the genome.
    Fursova NA; Turberfield AH; Blackledge NP; Findlater EL; Lastuvkova A; Huseyin MK; Dobrinić P; Klose RJ
    Genes Dev; 2021 May; 35(9-10):749-770. PubMed ID: 33888563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A common ancestry for BAP1 and Uch37 regulators.
    Sanchez-Pulido L; Kong L; Ponting CP
    Bioinformatics; 2012 Aug; 28(15):1953-6. PubMed ID: 22645167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An emerging model for BAP1's role in regulating cell cycle progression.
    Eletr ZM; Wilkinson KD
    Cell Biochem Biophys; 2011 Jun; 60(1-2):3-11. PubMed ID: 21484256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of B Lymphocyte Development by Histone H2A Deubiquitinase BAP1.
    Lin YH; Liang Y; Wang H; Tung LT; Förster M; Subramani PG; Di Noia JM; Clare S; Langlais D; Nijnik A
    Front Immunol; 2021; 12():626418. PubMed ID: 33912157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex.
    Ji Z; Mohammed H; Webber A; Ridsdale J; Han N; Carroll JS; Sharrocks AD
    Nucleic Acids Res; 2014 Jun; 42(10):6232-42. PubMed ID: 24748658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-nucleus RNA-seq reveals that MBD5, MBD6, and SILENZIO maintain silencing in the vegetative cell of developing pollen.
    Ichino L; Picard CL; Yun J; Chotai M; Wang S; Lin EK; Papareddy RK; Xue Y; Jacobsen SE
    Cell Rep; 2022 Nov; 41(8):111699. PubMed ID: 36417865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion.
    Perez-Garcia V; Lea G; Lopez-Jimenez P; Okkenhaug H; Burton GJ; Moffett A; Turco MY; Hemberger M
    Elife; 2021 Jun; 10():. PubMed ID: 34170818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of the tumor suppressor BAP1 causes myeloid transformation.
    Dey A; Seshasayee D; Noubade R; French DM; Liu J; Chaurushiya MS; Kirkpatrick DS; Pham VC; Lill JR; Bakalarski CE; Wu J; Phu L; Katavolos P; LaFave LM; Abdel-Wahab O; Modrusan Z; Seshagiri S; Dong K; Lin Z; Balazs M; Suriben R; Newton K; Hymowitz S; Garcia-Manero G; Martin F; Levine RL; Dixit VM
    Science; 2012 Sep; 337(6101):1541-6. PubMed ID: 22878500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
    Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
    Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.
    Yu H; Mashtalir N; Daou S; Hammond-Martel I; Ross J; Sui G; Hart GW; Rauscher FJ; Drobetsky E; Milot E; Shi Y; Affar el B
    Mol Cell Biol; 2010 Nov; 30(21):5071-85. PubMed ID: 20805357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis identifies novel binding partners of BAP1.
    Baas R; J van der Wal F; Bleijerveld OB; van Attikum H; Sixma TK
    PLoS One; 2021; 16(9):e0257688. PubMed ID: 34591877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.
    Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD
    BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair.
    Parrotta R; Okonska A; Ronner M; Weder W; Stahel R; Penengo L; Felley-Bosco E
    J Thorac Oncol; 2017 Aug; 12(8):1309-1319. PubMed ID: 28389374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.